Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials
- PMID: 10532384
Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials
Abstract
The enteric flora comprise approximately 95% of the total number of cells in the human body and are capable of eliciting immune responses while also protecting against microbial pathogens. However, the resident bacterial flora of the gastrointestinal tract (GIT) may also be implicated in the pathogenesis of several chronic conditions such as inflammatory bowel disease (IBD). The University College Cork-based Probiotic Research Group has successfully isolated and identified lactic acid bacteria (LAB) which exhibit beneficial probiotic traits. These characteristics include the demonstration of bile tolerance; acid resistance; adherence to host epithelial tissue; and in vitro antagonism of potentially-pathogenic micro-organisms or those which have been implicated in promoting inflammation. The primary objective of this report is to describe the strategy adopted for the selection of potentially effective probiotic bacteria. The study further describes the evaluation of two members of the resulting panel of micro-organisms (Lactobacillus salivarius subsp. salivarius UCC118 and Bifidobacterium longum infantis 35624) under in vitro conditions and throughout in vivo murine and human feeding trials. Specifically, an initial feeding study completed in Balb/c mice focused upon (i) effective delivery of the probiotic micro-organisms to the GIT and evaluation of the ability of the introduced strains to survive transit through, and possibly colonise, the murine GIT; (ii) accepting the complexity of the hostile GIT and faecal environments, development of a method of enumerating the introduced bacterial strains using conventional microbiological techniques; and (iii) assessment of the effects of administered bacterial strains on the numbers of specific recoverable indigenous bacteria in the murine GIT and faeces. Additional research, exploiting the availability of murine models of inflammatory bowel disease, demonstrated the beneficial effects of administering probiotic combinations of Lactobacillus salivarius UCC118 and Bifidobacterium longum infantis 35624 in prevention of illness-related weight loss. A further ethically-approved feeding trial, successfully conducted in 80 healthy volunteers, demonstrated that yoghurt can be used as a vehicle for delivery of Lactobacillus salivarius strain UCC118 to the human GIT with considerable efficacy in influencing gut flora and colonisation.
Similar articles
-
In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings.Am J Clin Nutr. 2001 Feb;73(2 Suppl):386S-392S. doi: 10.1093/ajcn/73.2.386s. Am J Clin Nutr. 2001. PMID: 11157346 Review.
-
Understanding why probiotic therapies can be effective in treating IBD.J Clin Gastroenterol. 2008 Sep;42 Suppl 3 Pt 1:S111-5. doi: 10.1097/MCG.0b013e31816d922c. J Clin Gastroenterol. 2008. PMID: 18806699 Review.
-
Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model.Appl Environ Microbiol. 2006 Sep;72(9):5799-805. doi: 10.1128/AEM.00109-06. Appl Environ Microbiol. 2006. PMID: 16957197 Free PMC article.
-
Immunology and probiotic impact of the newborn and young children intestinal microflora.Anaerobe. 2011 Dec;17(6):369-74. doi: 10.1016/j.anaerobe.2011.03.010. Epub 2011 Apr 16. Anaerobe. 2011. PMID: 21515397 Review.
-
[Probiotics for inflammatory bowel disease].Nihon Rinsho. 2005 May;63(5):776-80. Nihon Rinsho. 2005. PMID: 15881169 Review. Japanese.
Cited by
-
Response of serum biochemical profile, antioxidant enzymes, and gut microbiota to dietary Hong-bailanshen supplementation in horses.Front Microbiol. 2024 Feb 20;15:1327210. doi: 10.3389/fmicb.2024.1327210. eCollection 2024. Front Microbiol. 2024. PMID: 38444806 Free PMC article.
-
Antibacterial MccM as the Major Microcin in Escherichia coli Nissle 1917 against Pathogenic Enterobacteria.Int J Mol Sci. 2023 Jul 20;24(14):11688. doi: 10.3390/ijms241411688. Int J Mol Sci. 2023. PMID: 37511446 Free PMC article.
-
Anticancer properties of curcumin-treated Lactobacillus plantarum against the HT-29 colorectal adenocarcinoma cells.Sci Rep. 2023 Feb 17;13(1):2860. doi: 10.1038/s41598-023-29462-7. Sci Rep. 2023. PMID: 36801895 Free PMC article.
-
Milk Fermented with Pediococcus acidilactici Strain BE Improves High Blood Glucose Levels and Pancreatic Beta-Cell Function in Diabetic Rats.Food Sci Anim Resour. 2023 Jan;43(1):170-183. doi: 10.5851/kosfa.2022.e69. Epub 2023 Jan 1. Food Sci Anim Resour. 2023. PMID: 36789203 Free PMC article.
-
Tibetan Pig-Derived Probiotic Lactobacillus amylovorus SLZX20-1 Improved Intestinal Function via Producing Enzymes and Regulating Intestinal Microflora.Front Nutr. 2022 Mar 29;9:846991. doi: 10.3389/fnut.2022.846991. eCollection 2022. Front Nutr. 2022. PMID: 35425795 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous